200 related articles for article (PubMed ID: 34360817)
21. Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimaging.
Thomae D; Servaes S; Vazquez N; Wyffels L; Dedeurwaerdere S; Van der Veken P; Joossens J; Augustyns K; Stroobants S; Staelens S
Nucl Med Biol; 2015 Dec; 42(12):975-81. PubMed ID: 26330158
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor.
Hortala L; Arnaud J; Roux P; Oustric D; Boulu L; Oury-Donat F; Avenet P; Rooney T; Alagille D; Barret O; Tamagnan G; Barth F
Bioorg Med Chem Lett; 2014 Jan; 24(1):283-7. PubMed ID: 24291040
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor.
Stehouwer JS; Birnbaum MS; Voll RJ; Owens MJ; Plott SJ; Bourke CH; Wassef MA; Kilts CD; Goodman MM
Bioorg Med Chem; 2015 Aug; 23(15):4286-4302. PubMed ID: 26145817
[TBL] [Abstract][Full Text] [Related]
24. In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor.
Nebel N; Maschauer S; Kuwert T; Hocke C; Prante O
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589704
[TBL] [Abstract][Full Text] [Related]
25. Hetero-aryl bromide precursor fluorine-18 radiosynthesis and preclinical evaluation of a novel positron emission tomography (PET) tracer [
Huang G; Lu X; Qiu Y; Bi L; Ye P; Yang M; Shen Y; Jin H; Han J
Bioorg Med Chem; 2022 Nov; 73():116996. PubMed ID: 36126443
[TBL] [Abstract][Full Text] [Related]
26. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
[TBL] [Abstract][Full Text] [Related]
27. Development of the High-Affinity Carborane-Based Cannabinoid Receptor Type 2 PET Ligand [
Ueberham L; Gündel D; Kellert M; Deuther-Conrad W; Ludwig FA; Lönnecke P; Kazimir A; Kopka K; Brust P; Moldovan RP; Hey-Hawkins E
J Med Chem; 2023 Apr; 66(7):5242-5260. PubMed ID: 36944112
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of [
Haider A; Wang L; Gobbi L; Li Y; Chaudhary A; Zhou X; Chen J; Zhao C; Rong J; Xiao Z; Hou L; Elghazawy NH; Sippl W; Davenport AT; Daunais JB; Ahmed H; Crowe R; Honer M; Rominger A; Grether U; Liang SH; Ametamey SM
ACS Chem Neurosci; 2023 Oct; 14(20):3752-3760. PubMed ID: 37788055
[TBL] [Abstract][Full Text] [Related]
29. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
[TBL] [Abstract][Full Text] [Related]
30. Single-step radiosynthesis and in vivo evaluation of a novel fluorine-18 labeled hippurate for use as a PET renal agent.
Pathuri G; Hedrick AF; Awasthi V; Gali H
Nucl Med Biol; 2012 Nov; 39(8):1195-201. PubMed ID: 22898317
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.
Turkman N; Shavrin A; Paolillo V; Yeh HH; Flores L; Soghomonian S; Rabinovich B; Volgin A; Gelovani J; Alauddin M
Nucl Med Biol; 2012 May; 39(4):593-600. PubMed ID: 22226022
[TBL] [Abstract][Full Text] [Related]
32. Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging.
Sadeghzadeh M; Wenzel B; Gündel D; Deuther-Conrad W; Toussaint M; Moldovan RP; Fischer S; Ludwig FA; Teodoro R; Jonnalagadda S; Jonnalagadda SK; Schüürmann G; Mereddy VR; Drewes LR; Brust P
Molecules; 2020 May; 25(10):. PubMed ID: 32423056
[TBL] [Abstract][Full Text] [Related]
33. Preclinical Evaluation and Quantification of
Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system.
Ni R; Mu L; Ametamey S
Acta Pharmacol Sin; 2019 Mar; 40(3):351-357. PubMed ID: 29921889
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).
Wängler B; Schneider S; Thews O; Schirrmacher E; Comagic S; Feilen P; Schwanstecher C; Schwanstecher M; Shiue CY; Alavi A; Höhnemann S; Piel M; Rösch F; Schirrmacher R
Nucl Med Biol; 2004 Jul; 31(5):639-47. PubMed ID: 15219283
[TBL] [Abstract][Full Text] [Related]
36. Radiosynthesis of (S)-[
Sarasamkan J; Fischer S; Deuther-Conrad W; Ludwig FA; Scheunemann M; Arunrungvichian K; Vajragupta O; Brust P
Appl Radiat Isot; 2017 Jun; 124():106-113. PubMed ID: 28365525
[TBL] [Abstract][Full Text] [Related]
37. A Promising PET Tracer for Imaging of α₇ Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand.
Teodoro R; Scheunemann M; Deuther-Conrad W; Wenzel B; Fasoli FM; Gotti C; Kranz M; Donat CK; Patt M; Hillmer A; Zheng MQ; Peters D; Steinbach J; Sabri O; Huang Y; Brust P
Molecules; 2015 Oct; 20(10):18387-421. PubMed ID: 26473809
[TBL] [Abstract][Full Text] [Related]
38. Towards tropomyosin-related kinase B (TrkB) receptor ligands for brain imaging with PET: radiosynthesis and evaluation of 2-(4-[(18)F]fluorophenyl)-7,8-dihydroxy-4H-chromen-4-one and 2-(4-([N-methyl-(11)C]-dimethylamino)phenyl)-7,8-dihydroxy-4H-chromen-4-one.
Bernard-Gauthier V; Boudjemeline M; Rosa-Neto P; Thiel A; Schirrmacher R
Bioorg Med Chem; 2013 Dec; 21(24):7816-29. PubMed ID: 24183588
[TBL] [Abstract][Full Text] [Related]
39. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
Haider A; Gobbi L; Kretz J; Ullmer C; Brink A; Honer M; Woltering TJ; Muri D; Iding H; Bürkler M; Binder M; Bartelmus C; Knuesel I; Pacher P; Herde AM; Spinelli F; Ahmed H; Atz K; Keller C; Weber M; Schibli R; Mu L; Grether U; Ametamey SM
J Med Chem; 2020 Sep; 63(18):10287-10306. PubMed ID: 32787079
[TBL] [Abstract][Full Text] [Related]
40. Discovery of a Promising Fluorine-18 Positron Emission Tomography Radiotracer for Imaging Sphingosine-1-Phosphate Receptor 1 in the Brain.
Qiu L; Jiang H; Zhou C; Wang J; Yu Y; Zhao H; Huang T; Gropler R; Perlmutter JS; Benzinger TLS; Tu Z
J Med Chem; 2023 Apr; 66(7):4671-4688. PubMed ID: 36926861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
